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Abstract
Background: Noninvasive blood pressures (NIBP) and pulse pressures (PP) have not
been published in horses with aortic and mitral regurgitation (AR or MR).
Objectives: To investigate NIBP and PP in healthy Warmblood horses and horses
with AR and MR and propose PP cutoffs to identify and stage AR severity.
Animals: Seventy-three Warmblood horses (healthy, 10; AR, 31; MR, 32).
Methods: Retrospective study. All horses had NIBP and an echocardiogram recorded.
Cases were categorized based on severity of regurgitation. Pulse pressures were
compared among healthy, MR, and AR groups and among AR severity groups. Cutoffs
were determined by receiver operating characteristic curve analyses.
Results: Horses with AR had higher PP than horses with MR (mean difference [95%
confidence interval (CI)], +17 [9-26] mm Hg, P < .001) and controls (+17 [5-30] mm
Hg; P =.004). Horses with severe AR had higher PP compared those with mild (+38
[20-54] mm Hg; P < 0.001) and moderate AR (+33 [18-47] mm Hg; P < .001). The PP
cutoffs to distinguish AR from MR and controls were 38 mm Hg (sensitivity [Sn],
100%; specificity [Sp], 19%) for maximal Sn and 61 mm Hg (Sn, 43%; Sp, 100%) for
maximal Sp. The PP cutoffs to distinguish severe AR from mild and moderate AR
were 57 mm Hg (Sn, 100%; Sp, 70%) for maximal Sn and 77 mm Hg (Sn, 75%; Sp,
100%) for maximal Sp.
Conclusions and Clinical Importance: Horses with AR have increased PP. Noninvasive
PP measurements interpreted with provided cutoffs may aid clinicians in diagnosing
and staging severity of AR in horses.
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1 | INTRODUCTION
Aortic regurgitation (AR) is a common cardiac disease in horses,1–3
frequently reported in horses older than 10 years.3 Resulting in a
decrescendo diastolic (often musical) heart murmur, AR is easily diag-
nosed by careful auscultation. Although a typical diastolic murmur
indicates the presence of AR, the murmur alone cannot provide a
Abbreviations: ANOVA, analysis of variance; AR, aortic regurgitation; BWT, body weight;
DAP, diastolic arterial pressure; EF, left ventricular ejection fraction; FS, left ventricular
fractional shortening; HR, heart rate; LA, left atrial; LADmax, maximum left atrial diameter at
end systole; LADmax/LVIDd, ratio of maximum left atrial diameter to left ventricular internal
diameter at end diastole; LV, left ventricle; LVIDd, left ventricular internal diameter at end
diastole; LVIVd, left ventricular internal volume at end diastole; MAP, mean arterial pressure;
MR, mitral regurgitation; MWTd, left ventricular mean wall thickness at end diastole; NIBP,
noninvasive blood pressure; PP, pulse pressure; ROC, receiver operating characteristic curve;
RWTd, left ventricular relative wall thickness at end diastole; SAP, systolic arterial pressure;
Sn, sensitivity; Sp, specificity; SV, left ventricular stroke volume.
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definitive diagnosis or assessment of AR severity and hemodynamic
compensation.4,5 With an AR murmur typically being an incidental
finding on clinical examination, the presence of other clinical signs
such as exercise intolerance can vary and often even horses with
moderate to severe disease do not show any other outward clinical
signs.2,6
It is important to assess the severity and hemodynamic relevance
of AR, because left ventricular (LV) enlargement is considered a prog-
nostic indicator for disease progression and a risk factor for the devel-
opment of malignant ventricular arrhythmia and sudden cardiac death.2
Currently, echocardiography is the recommended method for objec-
tively estimating the clinical relevance of a heart murmur.5,7,8 Thereby,
the presence of AR is confirmed and its severity commonly evaluated
using the size of the regurgitant jet flow across the aortic valve into the
LV.9 This assessment does not take LV size or shape into consideration,
both of which are important for assessing the disease severity. A recent
study proposed additional severity scoring criteria, including LV diame-
ter and subjective LV appearance.10 This combined subjective and
objective assessment of LV size, shape, and regurgitant jet size is cur-
rently the recommended approach for assessing the AR severity. How-
ever, echocardiography requires specialized equipment and a high level
of training and operator experience to be accurate and reliable.
There is a need for a stall-side, objective measure of the hemody-
namic changes in horses with AR to aid in diagnosis and risk assess-
ment, and to monitor for progression of disease.
In hemodynamically relevant AR, there is both a decrease in dia-
stolic arterial pressure (DAP) as a result of diastolic run-off of blood
from the aorta into the LV through the insufficient valve and an
increase in systolic arterial pressure (SAP) as a result of increased pre-
load and activation of cardiac compensatory mechanisms (eg, the
Frank-Starling mechanism).11–13 The difference between SAP and
DAP is known as pulse pressure (PP). Clinically, this increased ampli-
tude of PP can be appreciated by palpation of a hyperkinetic (referred
to as hyperdynamic or a “water-hammer”) pulse. This finding has been
described as a subjective clinical marker of hemodynamically relevant
AR in horses.14–16
Noninvasive blood pressure (NIBP) measurement using a tail cuff
placed over the coccygeal artery is becoming easier to perform in the
field setting17 with the availability of portable measurement units, pro-
viding an objective measurement of PP (as opposed to subjective palpa-
tion of arterial pulse strength). In addition, NIBP measurement requires
less training and experience to perform when compared with echocar-
diography, allowing field clinicians to more easily assess and monitor
disease progression. Increased PP has been shown to be a feature of
human patients with AR18 and other cardiovascular diseases.19–22 One
(non-peer-reviewed) study found increased PP in horses with AR with
progression of disease,15 but no data using PP to identify the presence
or discriminate the severity of AR have been published to date.
The purpose of our study was to (1) measure NIBP, including PP,
in horses with AR and mitral regurgitation (MR) and compare these
results with those in healthy controls, (2) provide PP cutoffs that aid
in distinguishing horses with AR from horses with MR and healthy
controls, and (3) establish PP cutoffs that aid in distinguishing severe
cases of AR from mild and moderate cases. The hypotheses were that
horses with AR would have higher PP than horses with MR and con-
trol horses, and that horses with severe AR would have higher PP
than horses with mild or moderate disease.
2 | MATERIALS AND METHODS
2.1 | Study population and case selection
This retrospective study included horses that underwent standardized
echocardiographic examination at theUniversity of Zurich EquineHospi-
tal between April 2013 and July 2017. Enrollment criteria included a pri-
mary diagnosis of AR or MR with echocardiographic severity of mild
to severe (based on the size of the regurgitant jet), age >2 years,
Warmblood breed, complete physical examination performed, complete
echocardiographic examination of good quality (including 2-dimensional,
motionmode, andDoppler methods) performed by an experienced oper-
ator (Colin C. Schwarzwald or Katharyn J.Mitchell), and 5NIBPmeasure-
ments obtained using an NIBP monitor with simultaneously recorded
ECG. Control horses had to fulfill the same criteria concerning weight,
age, breed, and examinations performed but did not suffer from cardio-
vascular disease and had no or clinically irrelevant valve regurgitation on
echocardiography. Horses were excluded from the study if diagnosed
with atrial fibrillation or signs of heart failure, if the primary valvular insuf-
ficiency could not be clearly identified, or if they had been sedated
before the NIBP recordings were obtained. For horses with multiple
examinations, only the first examination of each horse performed during
the time periodwas included.
All examinations were performed according to institutional ethical
standards. All owners of clinical patients consented to the examina-
tions as part of the diagnostic evaluation of the presenting problem.
2.2 | Noninvasive blood pressure measurements
The NIBP measurements were recorded using an oscillometric
method (Medtronic LIFEPAK 15 monitor/defibrillator; Physio-Con-
trol, Inc, Redmond, Washington). All horses included in the study
were unsedated at the time of blood pressure measurement, and the
observer was unaware of the echocardiographic findings and clinical dis-
ease severity assessment. An inflatable cuff (Tuff Cuff; CAS medical sys-
tems, Inc, Branford, Connecticut) was applied securely to the base of the
horse's tail with the bladder of the cuff lying on the coccygeal artery on
the underside of the tail head. The cuff size was selected according to the
circumference of the base of the tail (cuff width: tail circumference,
0.4-0.6). Once the horse was in a relaxed state, at least 5 NIBP measure-
ments were recorded. Values were not corrected for tail height above
heart base. For each recording, the variables SAP, DAP,mean arterial pres-
sure (MAP), and heart rate (HR) were documented and PP was calculated
as PP = SAP − DAP. Measurements with clearly invalid results such as
inappropriate HR when compared to auscultation HR or pressure far out-
side the physiologically expected range (ie, SAP >200 mm Hg, DAP
<20 mm Hg) or if the horse was moving excessively were excluded, and
the measurement was repeated until 5 valid measurements had been
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obtained.23 For each variable, the average of the 5 recordings of each
horsewas determined and used for further analyses.
2.3 | Echocardiography
Transthoracic echocardiographic examinations and measurements
were performed by 2 experienced operators (Colin C. Schwarzwald
or Katharyn J. Mitchell) according to a standardized protocol.24–26
All horses were restrained by an experienced handler, and examina-
tions were performed when the horse was standing quietly with a
HR <50 bpm. A high-end echocardiograph (GE Vivid 7 Ultrasound
system; GE Healthcare, Glattbrugg, Switzerland) with a phased array
transducer (M4S phased array transducer; GE Healthcare) operated
at a frequency of 1.7/3.6 MHz (octave harmonics) was used. A
single-lead base-apex ECG was recorded simultaneously for timing
purposes. Recordings were stored as cine-loops in digital raw data
format for subsequent offline analysis (EchoPAC; GE Healthcare).
Three representative nonconsecutive cardiac cycles were measured
and averaged for each variable. Cycles immediately following a sinus
pause, second-degree atrioventricular block, or ectopic beat were
excluded from analysis. The HR of each measured cycle was calcu-
lated based on the RR interval (in milliseconds) preceding the ana-
lyzed cycle (HR = 60 000/RR). All measurements were performed
offline at the time of examination of the horses, adhering to a pre-
determined measurement protocol that was used throughout data
collection. The following variables were measured or calculated for
the AR and control group: pulmonary artery diameter at end diastole;
aortic sinus diameter at end diastole; maximum left atrial (LA) area
and maximum LA diameter (LADmax) at end systole, before mitral
valve opening; LV internal volume at end diastole (LVIVd); LV ejec-
tion fraction (EF); LV stroke volume (SV); LV internal diameter at end
diastole (LVIDd); LV fractional shortening (FS); LV relative wall thick-
ness at end diastole (RWTd); LV mean wall thickness at end diastole
(MWTd); and the ratio of maximum LA diameter to LV internal diam-
eter at end diastole (LADmax/LVIDd). Where appropriate, allometric
scaling was performed as previously described to correct for differ-
ences in body mass.27 Specifically, LA and LV dimensions were nor-
malized to a body weight (BWT) of 500 kg using the following
equations: diameter[500] = measured diameter/BWT
1/3 × 5001/3;
area(500) = measured area/BWT
2/3 × 5002/3, volume(500) = measured
volume/BWT × 500. Abnormalities detected on the valve leaflets,
extent of cardiac chamber enlargement, severity of the resultant vol-
ume overload, size of the regurgitant jet, and relative relationship of
jet size to chamber size were judged by the operators. Echocardio-
graphic data from the MR group were not reported because they
were not the focus of the study.
2.4 | Population grouping and AR severity scoring
Based on auscultation and echocardiographic diagnosis, the cases were
separated into groups “AR”, “MR,” and “Control,” and any other diagno-
ses were excluded. Horses in the control group were clinically healthy
and free of cardiac disease based on history, physical examination, and
transthoracic echocardiography. Horses in the AR group were further
sorted according to the severity of regurgitation (mild, moderate, or
severe), as judged by a scoring method that included subjective criteria
(regurgitant jet size, LV size, and apex shape) as well as objective criteria
(LVIVd(500)). The scoring system was modified from that previously
described10 in that LV volume rather than diameter was evaluated
according to current hospital echocardiography standards (see Supple-
mentary Table S1). Three clinicians (Julia Boegli, Colin C. Schwarzwald,
Katharyn J. Mitchell), blinded to the previous clinical assessment of the
horse, scored each horse, and the average of the 3 scores was used to
sort the horses into 3 groups. Age, sex, breed, BWT, reason for presen-
tation, primary and secondary diagnosis and corresponding severities,
NIBP measurements, HR, and subjective pulse quality obtained by digi-
tal palpation (moderate, strong, or hyperkinetic) were reported for
each case.
2.5 | Data analysis and statistical methods
Data collection, graphical presentation, data analysis, and statistics were
performed using commercially available computer software (Microsoft
Excel; Microsoft, Redmond, Washington; GraphPad Prism version 7.03;
GraphPad Software, Inc, San Diego, California; Sigmaplot version 12.3
for Windows; Systat Software GmbH, Erkrath, Germany).
Distribution and spread of the data were evaluated visually using
raw data with dot plots and box-and-whisker plots. Normally distrib-
uted data were reported as mean ± SD, whereas variables that were
not normally distributed were reported as median (minimum-maxi-
mum). The level of significance for all statistical analyses was P < .05.
A chi-squared test was used to compare the distribution of sex
among the control, AR, and MR groups. A Fisher's exact test was used
to compare subjective (palpation) assessment of pulse quality (hyper-
kinetic versus moderate or strong) with the echocardiographic sever-
ity score assessment (severe versus mild or moderate). Sensitivity
(Sn) and specificity (Sp) were calculated from the contingency table
using the Wilson-Brown method.28
Age, BWT, HR, SAP, DAP, MAP, and PP were compared among
the AR, MR, and control groups, and among the different AR severity
groups, respectively, using 1-way analysis of variance (ANOVA) and
Tukey's multiple comparisons post hoc test. Echocardiographic data
from the different AR severity groups and the control group also were
compared using 1-way ANOVA and Tukey's multiple comparisons
post hoc test. To investigate the influence of HR on PP measure-
ments, a multiple linear regression analysis was performed, with PP as
the dependent variable and HR and AR severity (reference-coded as
dummy variable) as independent variables. Normal distribution and
homoscedasticity of the residuals were confirmed by assessment of a
histogram, normal probability plot, and a scatterplot of the residuals.
Receiver operating characteristic curve (ROC) analysis was used to
determine PP cutoffs to distinguish AR cases from MR and control
groups and to distinguish horses with severe AR from those with mild
to moderate AR, respectively. Two separate cutoffs, including the cut-
off to maximize Sn and the cutoff to maximize Sp, were determined
for each ROC analysis. Additionally, the cutoff resulting in the highest
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Youden's index (Sp + Sn − 1), maximizing both the combined Sn and
Sp, was determined.29 The area under the curve, Sn, and Sp were
reported with their 95% confidence intervals. In addition, the positive
and the negative likelihood ratios were reported for each cutoff.
3 | RESULTS
3.1 | Study population and case selection
Ten control horses, 32 horses with MR, and 31 horses with AR were
identified in the medical records as meeting the inclusion criteria for
the study. Specific information on the study population can be found
in Tables 1 and 2.
Reasons for presentation were investigation of heart murmurs heard
incidentally on physical examination (AR, 18 horses; MR, 23 horses; con-
trol, 2 horses) or for follow-up examinations (AR, 9 horses; MR, 5 horses;
control, 1 horse), weakness or collapsing episodes (AR, 2 horses; MR,
2 horses; control, 1 horse), cough (AR, 1 horse), arrhythmia (MR, 1 horse;
control, 3 horses), decreased performance (MR, 1 horse; control, 3 horses),
and trauma (AR, 1 horse). The 10 control horses were considered car-
diovascularly normal (6 horses) or had clinically irrelevant (trace or trivial)
valve regurgitation (4 horses). The 3 horses presented for evaluation of
arrhythmia had physiological sinus arrhythmia and 2nd-degree atrioven-
tricular block at rest. Horses with decreased performance or collapse
were diagnosed with problems of other organ systems (left recurrent
laryngeal neuropathy, asthma, orthopedic disease).
The mean age of horses with AR was significantly higher when com-
pared to the MR and control group (Table 1), whereas BWT or sex did
not differ significantly among the 3 groups. Within the AR group, the
horses in the mild group were significantly younger than the horses in
the severe group (Table 2), but no difference in BWT was identified.
3.2 | Echocardiography of AR horses
The severity scoring system classified 8 horses with severe AR,
15 horses with moderate AR, and 8 horses with mild AR. Concurrent
MR was observed and considered trivial (2 horses), trivial to mild
(6 horses), mild (3 horses), or mild to moderate (3 horses) in horses
with AR as the primary valvular regurgitation. The echocardiographic
data are found in Table 2. Horses with severe AR had increased LA
diameter and area compared to control horses or horses with mild
AR. The LV size (LVIDd, LVIVd) was significantly larger, and RWTd and
LADmax/LVIDd were significantly lower in horses with severe AR com-
pared to all other groups. Horses with mild AR had significantly
increased MWTd. Although the indices of LV systolic function (EF and
FS) were not different among AR severity subgroups and control
horses, the SV of horses with severe AR was significantly increased
compared to horses with mild and moderate AR, as well as compared
to control horses.
3.3 | Noninvasive blood pressure measurements
Table 3 and Figures 1 and 2 compare the NIBP data among the 3 dis-
ease groups and within the AR severity subgroups. The AR group had
increased SAP compared to the MR group and increased PP compared
to the MR and control groups, whereas MAP and DAP were not dif-
ferent among the groups. Within the AR severity subgroups, horses
with severe AR had significantly decreased DAP and significantly
increased PP compared to horses with mild AR, but no significant dif-
ferences in SAP, MAP, or HR were found. Compared to horses with
moderate AR, horses with severe AR had significantly increased SAP
and significantly increased PP, but no significant differences in DAP,
MAP, or HR were found.
No significant effect of HR on PP was identified in the multiple
regression model (P = .4).
Results of the ROC analysis reporting the different cutoffs to dis-
tinguish AR from MR and control horses and to detect horses with
severe versus mild and moderate AR are found in Table 4 and Fig-
ures 1 and 2.
When subjective pulse quality (moderate or strong versus hyperki-
netic) was compared to the echocardiographic severity score (mild or
moderate versus severe), palpation of a hyperkinetic pulse was signifi-
cantly associated with severe AR (Fisher's exact test, P = .03). How-
ever, palpation of a hyperkinetic pulse did not perform as well as
NIBP measurement of PP for predicting severe AR (Sn, 50%; Sp, 91%;
positive likelihood ratio, 5.8). Figure 3 shows the PP measurements in
horses with a moderate and strong versus hyperkinetic pulse quality
on palpation.
4 | DISCUSSION
In our study, NIBP values were compared among horses with AR and
MR, and control horses to determine NIBP values that best indicate
the presence and severity of AR. The results indicate that PP can be
TABLE 1 Population characteristics of the main disease groups
Main disease groups
F-test
P valueControl MR AR
n 10 32 31
Age (years) 10 ± 5a 11 ± 5a 17 ± 5b <.001
Sex
Female 4 8 8 .63
Male 6 24 23
Body weight (kg) 595 ± 33 576 ± 50 584 ± 51 .58
Pulse quality
Moderate 1 3 2 nt
Strong 9 29 23 nt
Hyperkinetic 0 0 6 nt
Numerical values are reported as mean ± SD. Significance was set at
P < .05. Different-letter superscripts are indicative of a significant
difference, whereas the same-letter superscripts indicates there is no
difference among the groups.
Abbreviations: AR, aortic regurgitation; MR, mitral regurgitation; n,
number of horses; nt, not tested.
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used as a diagnostic aid in detection and staging of AR severity in
horses.
4.1 | Noninvasive blood pressures
The mean SAP, DAP, MAP, and HR recorded for the MR and control
groups in our study were similar to the reference values reported in the
veterinary medical literature using an ultrasonic blood flow detector
technique and an oscillometric method.30,31 Although PP of healthy
horses is only specifically reported in a single paper,30 reference values
for PP can be deduced from other reported SAP and DAP values
obtained in healthy horses and were similar to those found in our con-
trol horses.31 Correction for tail height above heart base is necessary to
evaluate the accuracy of NIBP measurements of SAP, DAP, and MAP
among different sized horses but is redundant when assessing changes
in PP, because both SAP and DAP will change by the same magnitude
in a given horse. Although the tail height above heart base was not
recorded in our study, an attempt to standardize the population of
horses was made by including only horses of Warmblood breed older
than 2 years. Body weight did not differ among the groups of horses,
making it more likely that the horses included in our study were of a
similar stature.
4.2 | NIBP differences in AR, MR, and control horses
Pulse pressure was significantly increased in horses with AR compared
to horses with MR and healthy controls. Similar results have been
found in human medicine, and widened PP can be a diagnostic aid for
TABLE 2 Population and echocardiographic characteristics of each AR severity subgroup and the control group
AR groups
Control
F-test
p valueMild Moderate Severe
n 8 15 8 10
Age (years) 14 ± 6a,c 17 ± 3a,b 20 ± 5b 10 ± 5c .045
Sex
Female 4 4 0 4 nt
Male 4 11 8 6
Body weight (kg) 588 ± 69 587 ± 44 573 ± 48 595 ± 33 .807
Pulse quality
Moderate 1 1 0 1 nt
Strong 7 12 4 9 nt
Hyperkinetic 0 2 4 0 nt
AR severity score 5 (4-5) 7 (6-9) 11 (10-13) nt
Echocardiographic dimensions
PADed (cm) 6.8 ± 0.6
a 7.2 ± 0.5a 7.5 ± 0.8a 6.8 ± 0.6a .034
AoDed (cm) 8.4 ± 0.8 8.3 ± 0.8 8.2 ± 0.4 7.8 ± 0.7 .19
LAAmax (500) (cm
2) 90 ± 14a 97 ± 11a,b 107 ± 12b 87 ± 8a .002
LADmax (500) (cm) 11.7 ± 1.1
a,c 12.3 ± 0.7a,b 13.2 ± 0.8b 11.2 ± 0.7c <.001
LVIDd (500) (cm) 11.1 ± 0.5
a 12.4 ± 1.2b 15.1 ± 1.3c 10.8 ± 0.6a <.001
LVIVd (500) (mL) 1078 ± 165
a,c 1309 ± 204a,c 2067 ± 451b 1043 ± 137c <.001
RWTd 0.59 ± 0.07
a 0.47 ± 0.06b 0.38 ± 0.06c 0.53 ± 0.07a,b <.001
MWTd (cm) 3.4 ± 0.4
a 3.0 ± 0.2b 3.0 ± 0.3b 3.0 ± 0.3b .005
LADmax/LVIDd 1.1 ± 0.1
a 1.0 ± 0.1a 0.9 ± 0.1b 1.0 ± 0.1a .001
FS (%) 42 ± 8 39 ± 7 40 ± 4 45 ± 4 .18
EF (%) 71 ± 4 73 ± 4 73 ± 4 75 ± 4 .12
SV (mL) 888 ± 144a,c 1120 ± 211a,c 1754 ± 516b 931 ± 119c <.001
HR (bpm) 39 ± 10 36 ± 7 38 ± 5 39 ± 5 .59
Numerical values are reported as mean ± SD or median (range). Severity score is based on a modified scoring method, see Supplementary Table S1.
Significance was set at P < .05. Different-letter superscripts are indicative of a significant difference, whereas the same-letter superscript indicates there is
no difference between groups.
Abbreviations: AoDed, aortic sinus diameter at end diastole; AR, aortic regurgitation; EF, ejection fraction; FS, fractional shortening; HR, heart rate; LAAmax
(500), maximum left atrial area, allometrically scaled to 500 kg; LAD/LVIDd, ratio of maximum left atrial diameter to left ventricular internal diameter at end
diastole; LADmax (500), maximum left atrial diameter, allometrically scaled to 500 kg; LVIDd (500), left ventricular internal diameter at end diastole,
allometrically scaled to 500 kg; LVIVd (500), left ventricular internal volume at end diastole, allometrically scaled to 500 kg; MWTd, mean wall thickness at
end diastole; n, number of horses; PADed, pulmonary artery diameter at end diastole; RWTd, relative wall thickness at end diastole; SV, stroke volume.
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TABLE 3 (A) Noninvasive blood pressure values of all horses in each groupa; (B) F-test and post hoc P-values of the comparison in one-way
ANOVA
Main groups comparison AR groups comparison
(A) Control (n = 10) MR (n = 32) AR (n = 31) Mild (n = 8) Moderate (n = 15) Severe (n = 8)
HR (bpm) 38 ± 4 39 ± 7 39 ± 6 36 ± 7 41 ± 14 40 ± 2
SAP (mm Hg) 116 ± 10 118 ± 12 127 ± 18 126 ± 17 120 ± 15 142 ± 15
MAP (mm Hg) 88 ± 9 88 ± 11 85 ± 14 93 ± 14 83 ± 13 80 ± 15
DAP (mm Hg) 71 ± 9 73 ± 11 65 ± 15 76 ± 11 65 ± 12 55 ± 17
PP (mm Hg) 45 ± 8 45 ± 7 62 ± 20 50 ± 8 55 ± 11 88 ± 21
Main groups comparison AR groups comparison
(B)
F-Test
P-value
Tukey's multiple comparisons
post hoc P-value
F-Test
P-value
Tukey's multiple comparisons
post hoc P-value
HR (bpm) .88 .53
SAP (mm Hg) .02 C versus MR = .94; C versus AR = .09;
MR versus AR = .03
.009 Mi versus Mo = .61; Mi versus S = .11;
Mo versus S = .007>
MAP (mm Hg) .19 .13
DAP (mm Hg) .05 .02 Mi versus Mo = .16; Mi versus S = .011;
Mo versus S = .23
PP (mm Hg) <.001 C versus MR = .99; C versus AR = .004;
MR versus AR < .001
<.001 Mi versus Mo = .72; Mi versus S < .001;
Mo versus S < .001
Significant differences between groups are highlighted in iltalics.
Abbreviations: ANOVA, analysis of variance; AR, aortic regurgitation; C, control; DAP, diastolic arterial pressure; MAP, mean arterial pressure; Mi, mild
aortic regurgitation; Mo, moderate aortic regurgitation; MR, mitral regurgitation; PP, pulse pressure; S, severe aortic regurgitation; SAP, systolic arterial
pressure.
aA one-way ANOVA with Tukey's multiple comparison post hoc test was performed. Level of significance was set at P < .05. Values are reported as
mean ± SD.
F IGURE 1 Dot plot showing pulse pressure measurements from
control horses compared with horses diagnosed with mitral (MR) or
aortic (AR) regurgitation. The mean and SD for each group is
displayed. The red dotted lines represent the receiver operating
characteristic curve analysis cutoffs of highest sensitivity (38 mm Hg),
highest specificity (61 mm Hg), and the Youden index-based cutoff
(48 mm Hg). Significant differences were detected with a 1-way
analysis of variance, between control horses and horses with AR
(P = .004) and between horses with AR and MR (P < .001)
F IGURE 2 Dot plot showing pulse pressuremeasurements from
horseswithmild, moderate and severe aortic regurgitation (AR). Themean
and SD for each group is displayed. The red dotted lines represent the
receiver operating characteristic curve analysis cutoffs of highest
sensitivity (57 mmHg), highest specificity (77 mmHg), and theYouden
index-based cutoff (63 mmHg). Significant differenceswere detectedwith
a 1-way analysis of variance, between horseswithmild and severe AR
(P < .001) and between horseswithmoderate and severe AR (P< .001)
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identifying people with AR.12 In a study on experimental AR in anesthe-
tized dogs, PP increased from 23 ± 4 mm Hg before AR induction to
61 ± 22 mm Hg after AR induction.32 In another study, anesthetized
dogs with experimentally induced AR experienced an immediate widen-
ing of PP once regurgitation occurred.13 Physiologically, this can be
explained by considering the cardiovascular changes that AR causes. In
AR, the diastolic runoff of regurgitant blood flow from the aorta back
into the LV causes a decrease in DAP. When the regurgitant volume is
hemodynamically relevant, it adds substantially to ventricular preload,
activating the Frank-Starling mechanism and increasing stroke volume.
The increased volume of blood ejected into the aorta then results in a
steady or even increased SAP. Clinically, individuals with severe AR
often have hyperkinetic or “water hammer” pulses,11,12,16,33,34 which
can be felt as a bounding pulse when palpating a peripheral artery.
In our study, the widened amplitude between SAP and DAP is
illustrated by the higher PP in horses with AR compared to control
horses and horses with MR, and in horses with increasing severity of
AR. In this group of horses with AR, there was no apparent effect of
HR on PP. This is an interesting finding, because horses with lower
HR would have longer periods of diastole and larger regurgitant vol-
umes entering the LV, theoretically resulting in lower DAP, whereas
the effect should be opposite (increasing DAP) in horses with higher
HR. The lack of a wider range in HR in this population of horses pre-
vents this hypothesis from being fully tested.
The significantly increased PP values in Warmblood horses with AR
may aid clinicians in the field when confirming AR if echocardiography is
unavailable, when determining whether a horse with AR should be
referred for further evaluation or when assessing whether the disease
has progressed in severity. Invasive blood pressure monitoring is uncom-
monly performed in field practice, but NIBP monitoring presents a tool
that could be implemented easily in the field setting.31,35–41
The provided PP cutoffs (Table 4) can be implemented in clinical
situations, depending on whether a high Sn or high Sp is required for
TABLE 4 Receiver operating characteristic curve analyses
AUC PP cutoff Sn (%) Sp (%)
Positive LR Negative LR(95% CI) (mm Hg) (95% CI) (95% CI)
AR versus MR and control 0.83
(0.74-0.93)
High Sn 38 100 19 1.2 0
(88-100) (8-33)
Youden Index 48 83 74 3.3 0.23
(65-94) (59-87)
High Sp 61 43 100 ∞ 0.57
(26-63) (92-100)
Severe versus mild and moderate AR 0.94
(0.85-1.00)
High Sn 57 100 70 3.3 0
(63-100) (47-87)
Youden Index 63 88 83 5 0.15
(47-100) (61-95)
High Sp 77 75 100 ∞ 0.25
(35-97) (85-100)
Pulse pressure cutoff values and respective sensitivities, specificities, and likelihood ratios to diagnose AR versus MR and control horses and severe AR
versus mild and moderate AR, respectively.
Abbreviations: AR, aortic regurgitation; AUC, area under curve; CI, confidence interval; LR, likelihood ratio; MR, mitral regurgitation; PP, pulse pressure;
Sn, sensitivity; Sp, specificity.
F IGURE 3 Dot plot showing the corresponding pulse quality
(moderate and strong, hyperkinetic) versus pulse pressure
measurements from horses with AR. The mean and SD for each group
is displayed. The red dotted line represents the receiver operating
characteristic curve cutoff with the highest specificity (77 mm Hg)
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disease classification. If the aim is to rule out a horse having AR, a
PP < 38 mm Hg indicates a horse is unlikely to have AR, whereas a
PP > 61 mm Hg is highly indicative of AR. Pulse pressures ranging
between 38 and 61 mm Hg represent an equivocal zone, and the
Youden index-based cutoff of 48 mm Hg may lack sufficient diagnos-
tic accuracy to be clinically useful. The PP cutoffs to determine the
severity of AR function in the same way. Obtaining results above the
cutoff of 77 mm Hg will identify most horses with severe AR. Results
below the cutoff of 57 mm Hg will identify horses that most likely do
not have severe AR. Again, the PP range of 57-77 mm Hg represents
an equivocal zone, containing the Youden index-based cutoff of
63 mm Hg. These cutoffs may assist clinicians when judging the
hemodynamic relevance of AR in an individual horse in combination
with auscultation and other physical examination findings.
Monitoring the progression of AR is important because horses
with hemodynamically relevant AR are anecdotally reported to be at
an increased risk of collapse and sudden cardiac death.2 Hence, inde-
pendent of the respective cutoffs, monitoring PP over time might aid
in detecting clinically relevant progression of AR in individual horses.
In our study, NIBP and echocardiographic evaluation only were per-
formed at a single time point. Further studies will be required to see
how PP trends change in the same horse over time if AR severity pro-
gresses and to determine the magnitude of increase in PP that would
suggest clinically relevant progression of disease. It is also conceivable
that if AR progresses to the point of myocardial failure, PP could theo-
retically decrease, particularly if systemic and LV pressures equalize in
a hemodynamically unstable patient. Longer term monitoring of PP in
AR patients would give valuable insight into the pathophysiology and
hemodynamic changes associated with progression of AR.
Comparison between subjective assessment of peripheral pulses by
digital palpation and objective PP assessment utilizing NIBP measure-
ments showed that although palpation of a hyperkinetic pulse is
strongly indicative of severe AR, not all horses with severe AR will have
this clinical finding. This observation may be related partly to the body
condition score of the horse as well as individual clinician skill and expe-
rience. Therefore, utilizing NIBP measurement of PP improves diagnos-
tic accuracy compared to physical examination alone.
4.3 | Echocardiography
Echocardiographic measurements were reported for documentation
and description of the different AR severity groups. Because indices
of LV size were included in the AR severity scoring system used to
classify AR severity, it is logical that these indices would be different
among the AR severity subgroups. The extent of LV enlargement in
the AR severity subgroups was similar to that recently reported in
other studies assessing the severity of AR using echocardiographic
measurements.10,42,43 However, it is also clear that horses with severe
AR show signs of LA enlargement indicating the hemodynamic rele-
vance of severe AR resulting in increased preload of both the LV and
LA. The finding of increased MWTd and RWTd in horses with mild AR
indicates that some concentric remodeling occurs in this population of
horses, whereas the decreased RWTd seen in the horses with severe
AR indicates that the chamber enlargement is becoming dispropor-
tionate to wall thickness. The fact that indices of LV systolic function
are not different among the AR severity subgroups highlights the diffi-
culty in using these variables to judge the severity of AR, as has been
described in 2 recent studies evaluating other methodologies to iden-
tify subtle changes in myocardial function.42,43
Our study does not assert that NIBP measurements should replace
echocardiography in the assessment of horses with AR. Rather, NIBP
measurements, and particularly PP measurements, can provide additional
information on the hemodynamic relevance of AR to guide practitioners
in their assessment of these horses in both field and hospital settings.
5 | LIMITATIONS
Because of the nature of case selection in this retrospective study, the
size of the control group was small in comparison to the AR and MR
groups. This likely caused a lack of statistical power to detect some dif-
ferences among the groups (eg, differences in DAP among the disease
groups). In addition, the control group was a convenience sample that
contained horses that were presented to the hospital for evaluation of
arrhythmia, murmur, poor performance, or collapse. These horses were
found to be cardiovascularly normal, and the NIBP ranges were similar
to those reported previously for healthy horses.30,31
Additionally, the within-day and between-day variability of PP
measurements in both healthy horses and horses with AR was not
documented. A recent study (data unpublished) from our laboratory
has found that PP measurement in healthy horses has a within-
day/within-operator coefficient of variation of 10.3% and a between-
day/within-operator coefficient of variation of 8.8%, both of which
are considered acceptable amounts of variation. However, we cur-
rently do not have any data on the variability of PP measurements in
horses with AR, and further research in this area is required.
Another limitation of our study is the possibility of classification bias
of disease severity. The AR scoring system implemented both objective
and subjective criteria to minimize bias and a similar scoring system previ-
ously had been described,10 but neither of the scoring systems has yet
been validated, because of a lack of a reference standard to categorize AR
severity in horses. Additionally, in the MR group, the severe category was
underrepresented in comparison to the severe category in the AR group
(data not shown), because individuals with severe MR often suffer from
secondary atrial remodeling and may present with atrial fibrillation.1,44
The NIBP monitors misreport blood pressure values when a horse is
arrhythmic, which was the reason why horses with atrial fibrillation were
excluded from our study. The relevance of this underrepresentation is
unclear and should be further investigated, but the hemodynamic effects
of severeMR are not considered likely to affect PP.
Older horses were overrepresented in the AR group; similar results
have been reported in previous studies investigating the epidemiology
of AR in horses.2,3,6 The effect of age (independent of AR) on PP is
unknown in horses, although in human patients PP is reported to
increase with age, as a result of vascular stiffness leading to increased
SAP.45 A much larger study population with individuals of various ages
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would be required to investigate any association between age and PP
in horses. This was beyond the scope of our study. In addition, various
other cardiovascular diseases can result in a widening of PP in people
(including systemic hypertension and atherosclerosis),20,22 and thus PP
always should be interpreted in conjunction with physical examination
findings and the presence of a left-sided diastolic murmur. If an
increased PP is identified in a horse without appreciable AR, the horse
should be evaluated for the presence of other cardiovascular diseases
(eg, aortic-cardiac fistula, systemic hypertension).
Lastly, our results are only valid for Warmblood horses and when
NIBP is measured using an identical NIBP monitoring device with the
appropriate cuffs. Extrapolation to other horse breeds, other monitors,
or different cuff types should not be attempted unless appropriate
validation studies have been performed.
6 | CONCLUSIONS
In conclusion, calculation of PP from NIBP measurements can provide
an objective assessment of the hemodynamic consequences of AR in
Warmblood horses. Measurement of NIBP in horses is a straightfor-
ward procedure that can be performed easily in a field setting.
Although NIBP cannot replace echocardiography in diagnosing and
staging severity of valvular disease, it can provide additional objective
data on the cardiovascular state of a horse suffering from AR, thus
aiding the clinician in determining the clinical relevance of a heart
murmur. By utilizing the provided cutoffs of PP, clinicians can assess
the likelihood of AR being hemodynamically relevant and provide
additional information to owners and riders. Further studies will be
required to define the clinical value of sequential PP measurements
over time to monitor clinically relevant progression of AR.
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